chromatogram
TL4 Analytical chemist · Ghent, BE
Reversed-phase peptide separations for a living. I will read your chromatogram if you post the axes, the gradient, and the injection volume. Without those it is a picture, not data.
Joined 19 May 2024 · last posted 4h · groups: analytical-chemists, wiki-editors, regional-na, trust-level-4
184 posts, newest first. Showing up to 150.
-
When a network meta-analysis is defensible and when it is not Replied, post #3 · marked as the solution · Evidence › Meta-analyses · 28 Jul 2026 · 7 likes Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by quality, to see whether the pooled estimate changes. Robust results…
-
Revisiting: Theoretical plates: useful number or ritual? Replied, post #22 · Analytics › HPLC & UHPLC · 26 Jul 2026 · 5 likes Gradient delay volume differs between instruments and shifts the whole chromatogram. It is why a transferred method rarely reproduces retention times exactly on a…
-
What is genuinely unknown about long-term amylin agonism Replied, post #88 · Compounds › Cagrilintide & amylin analogues · 26 Jul 2026 · 28 likes Post #86 put the caveat in the right place and I want to underline it. Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #95 · Wellbeing › Sleep · 25 Jul 2026 · 33 likes Eating patterns shift substantially and late intake affects sleep independently of anything pharmacological. One case, stated as one case.
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #110 · Evidence › Journal club · 24 Jul 2026 · 0 likes Following this. I have the same question and no better information than the first post.
-
Forced degradation studies: designing one that is informative Replied, post #104 · Analytics › Method validation · 22 Jul 2026 · 0 likes Small correction to my own earlier position on forced degradation studies. I had the units the wrong way round, which changes the conclusion by an order of magnitude…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #70 · Outcomes › Body composition · 22 Jul 2026 · 17 likes Post #67 is the version of this I will quote in future. One addition. Adding the boring version of ultrasound and skinfolds, because the interesting version keeps…
-
A structured critique template this community uses Replied, post #2 · Evidence › Study critique · 22 Jul 2026 · 0 likes Where a critique rests on a subgroup, check whether the interaction was tested. A difference between subgroups that is not statistically supported is not a difference.…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #99 · Start Here › Welcome · 21 Jul 2026 · 10 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
-
Publication patterns in the BPC-157 literature, examined Replied, post #39 · Compounds › Repair & healing peptides · 19 Jul 2026 · 12 likes Two people in this thread mean different things by publication patterns and are disagreeing about the definition while believing they are disagreeing about the facts.…
-
A structured critique template this community uses — a second dataset Replied, post #41 · Evidence › Study critique · 17 Jul 2026 · 3 likes Two things can be true about structured critique template at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #64 · Nutrition & Training › Protein & intake · 14 Jul 2026 · 0 likes This follows post #61 rather than contradicting it. On Protein density versus volume, I would rather understate and be corrected upward than overstate and be quoted.…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #93 · Start Here › Welcome · 14 Jul 2026 · 20 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #48 · Pharmacology › Pharmacokinetics · 12 Jul 2026 · 0 likes Steady state is approached in roughly four to five half-lives. For a compound with a week-long half-life that is four to five weeks, which is where the escalation…
-
Alcohol: what is documented and what is folklore Replied, post #105 · Practice › Interactions · 11 Jul 2026 · 0 likes On alcohol the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #67 · Compounds › Secretagogues & GH axis · 8 Jul 2026 · 0 likes The arithmetic in post #64 is right; the assumption feeding it is the part to check. Since secretagogues and glucose tolerance keeps coming up, it should probably be a…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #59 · Analytics › Home & field testing · 6 Jul 2026 · 16 likes Two claims get bundled together under consumer-accessible tests and they need separating. The descriptive one — this is what was observed — is usually well supported.…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #59 · Practice › Dosing & titration · 6 Jul 2026 · 4 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #38 · Practice › Administration · 4 Jul 2026 · 0 likes I read post #34 twice before replying, because I had assumed the opposite. Angle of injection is worth one more sentence than it usually gets, and the sentence is the…
-
Revisiting: Theoretical plates: useful number or ritual? Replied, post #17 · Analytics › HPLC & UHPLC · 4 Jul 2026 · 30 likes Post #15 and I disagree about the size of the effect, not about the direction. Reporting rather than recommending, on Theoretical plates. What happened is above.…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #56 · Compounds › Secretagogues & GH axis · 30 Jun 2026 · 10 likes Taking post #55 at face value and following it one step further. Speaking only to secretagogues and glucose tolerance as I have actually seen it, rather than as it is…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #38 · Access › Pricing · 29 Jun 2026 · 5 likes The arithmetic in post #37 is right; the assumption feeding it is the part to check. Genuine question rather than a rhetorical one: has anyone here actually observed…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #44 · Access › Insurance & coverage · 29 Jun 2026 · 10 likes Post #41 is right about the mechanism and I think understates the practical bit. Nothing here is legal or medical advice, and appeal processes differ enough by…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #35 · Analytics › Method validation · 26 Jun 2026 · 32 likes Narrowing post #32, because the general version has more than one answer. Robustness testing deliberately varies the parameters most likely to drift — organic…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #132 · Access › Insurance & coverage · 21 Jun 2026 · 22 likes Fair, and the limits you put on it are the part I will remember.
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #51 · Analytics › Home & field testing · 18 Jun 2026 · 24 likes I have three months of notes on Lateral-flow and colorimetric approaches and the honest summary is that the trend is real and the week-to-week numbers are noise. I…
-
Vomiting: when it is expected and when it is a reason to stop — one year on Replied, post #14 · Practice › Side effects · 12 Jun 2026 · 29 likes Severe, persistent abdominal pain, especially radiating to the back, is in a different category from ordinary gastrointestinal upset and is a reason to seek medical…
-
Revisiting: What pooling buys you and what it destroys Replied, post #46 · Evidence › Meta-analyses · 7 Jun 2026 · 1 like Coming back to post #44, because the follow-up matters more than the original answer. Study quality and weighting: some meta-analyses weight all studies equally; others…
-
What steady state means for the decision to escalate Replied, post #10 · Practice › Dosing & titration · 6 Jun 2026 · 0 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
-
A parcel stationary at a customs facility for nine days Replied, post #66 · Sourcing › Logistics · 2 Jun 2026 · 5 likes What I want from this parcel stationary thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
-
What would change my mind about repair peptides: a specific answer Replied, post #4 · Compounds › Repair & healing peptides · 29 May 2026 · 0 likes Noted, and I have changed what I was going to do on the strength of it.
-
Spreadsheets: an appreciation — what changed since Replied, post #54 · Lounge › Off topic · 27 May 2026 · 7 likes Lounge question, no agenda: does anyone else keep a physical notebook for this rather than a file? Mine is more use than anything I have typed, and I cannot entirely…
-
An 18-month record including the parts that went badly Replied, post #21 · Outcomes › Progress reports · 21 May 2026 · 8 likes Checked the 18-month record claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
-
Alcohol: what is documented and what is folklore Replied, post #19 · Practice › Interactions · 19 May 2026 · 1 like Two things can be true about alcohol at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is people…
-
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #22 · Practice › Dosing & titration · 17 May 2026 · 0 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
Bariatric surgery history: altered anatomy, altered expectations Started this topic · Clinical › Special populations · 5 May 2026 · 7 likes Posting this under the heading it deserves: Bariatric surgery history: altered anatomy, altered expectations Everything below is what sits behind that. Asking about…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #47 · Evidence › Journal club · 3 May 2026 · 6 likes On indirect comparison, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #60 · Sourcing › Vendor reports · 2 May 2026 · 4 likes Comparing your result to somebody else's on a different lot is not a comparison of suppliers. Lot is the unit and it should be in every report.
-
Blind submission and why it changes minds — the long version Replied, post #45 · Sourcing › Independent verification · 28 Apr 2026 · 5 likes Post #44 is the version of this I will quote in future. One addition. It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #23 · Devices › Syringes & needles · 24 Apr 2026 · 27 likes Post #19 and I disagree about the size of the effect, not about the direction. A detachable luer needle plus hub can retain enough volume to matter. Whether it matters…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #20 · Practice › Reconstitution · 22 Apr 2026 · 20 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. The evidence…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #95 · Practice › Reconstitution · 20 Apr 2026 · 0 likes This is the sort of exchange that makes the archive worth searching.
-
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #17 · Compounds › Semaglutide · 13 Apr 2026 · 24 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #12 · Practice › Reconstitution · 11 Apr 2026 · 12 likes Everything in post #8 holds. The case it does not cover is the one I have. 5 mg vial has been discussed here with more heat than it deserves, mostly because two…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #63 · Analytics › Method validation · 9 Apr 2026 · 10 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
A plateau that disappeared when I changed how I measured — the long version Replied, post #24 · Outcomes › Progress reports · 7 Apr 2026 · 7 likes Building on post #23 rather than restating it. Where I have landed on plateau, having got it wrong once in public: the direction is clear, the magnitude is not, and…
-
Coming back to: Training through a dose escalation week Replied, post #67 · Nutrition & Training › Resistance training · 1 Apr 2026 · 30 likes The reports here that state the programme, the load and the timeframe are useful. The ones that state an outcome are not. Stating my assumptions rather than smuggling…
-
Coming back to: Training through a dose escalation week Replied, post #56 · Nutrition & Training › Resistance training · 19 Mar 2026 · 32 likes This follows post #55 rather than contradicting it. Where training is new, the early gains are largely neural, which is why they can appear even during a deficit and do…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #78 · Lounge › Introductions · 16 Mar 2026 · 29 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #61 · Compounds › Cagrilintide & amylin analogues · 13 Mar 2026 · 27 likes Research-use-only cagrilintide is not approved for human use and the published evidence base is a clinical-trial evidence base. Those two facts sit uncomfortably…
-
Which fields on a certificate actually matter, ranked Replied, post #8 · Analytics › COA interpretation · 12 Mar 2026 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #48 · Data & Tools › Calculators · 11 Mar 2026 · 6 likes Saving this. It is the version I will quote when the question comes round again.
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #28 · Compounds › Repair & healing peptides · 10 Mar 2026 · 7 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #54 · Compounds › Cagrilintide & amylin analogues · 10 Mar 2026 · 9 likes Helpful, and short, which on this subject is harder than long.
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #65 · Outcomes › Body composition · 9 Mar 2026 · 0 likes Worth separating Circumference measurements as a question about the compound from Circumference measurements as a question about the documentation. They get answered by…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #28 · Practice › Administration · 7 Mar 2026 · 2 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Second pass at: Identical chromatograms across two different lots Replied, post #26 · Sourcing › Red flags · 25 Feb 2026 · 11 likes The strongest single signal available cheaply is what happens when you ask a technical question. A quantitative answer inside a working day is difficult to fake at…
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #33 · Compounds › Semaglutide · 22 Feb 2026 · 0 likes The 2.4 mg maintenance dose in the weight-management programme and the 1.0 mg diabetes dose are frequently discussed as though they were the same drug at different…
-
Revisiting: Absolute versus relative contraindications Replied, post #30 · Safety › Contraindications · 22 Feb 2026 · 2 likes One more thing on Absolute versus relative contraindications that took me far too long to see: the two figures people quote are not measuring the same quantity. Once…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #110 · Practice › Dosing & titration · 20 Feb 2026 · 0 likes If you are stepping up mainly because the schedule says so rather than because the current dose has stopped doing what you wanted, that is worth noticing before rather…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #68 · Analytics › Impurities & related substances · 19 Feb 2026 · 4 likes Confirming post #67 from a second method, which matters more than confirming it from a second person. Storage-related degradation and synthesis-related impurity look…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #70 · Outcomes › Progress reports · 17 Feb 2026 · 13 likes My position on Seven-day rolling is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
Mass error in ppm: the arithmetic and the caveat Replied, post #89 · Analytics › Mass spectrometry · 15 Feb 2026 · 5 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
-
Blinding yourself: practical methods and their limits Replied, post #5 · Research Methods › N-of-1 designs · 13 Feb 2026 · 11 likes Bookmarking this. I will come back when I have something worth adding.
-
Filter needles: when they help and what they cost you Replied, post #51 · Devices › Syringes & needles · 12 Feb 2026 · 12 likes U-100 means the barrel is graduated for a solution containing one hundred units of insulin per millilitre. For anything that is not insulin, the units are simply…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #14 · Evidence › Journal club · 2 Feb 2026 · 30 likes Picking up post #11: that is the part I would want checked first. Practical answer on SURMOUNT-1, since the theoretical one is upthread: do the simplest check first,…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #37 · Clinical › Special populations · 22 Jan 2026 · 9 likes Pregnancy and pregnancy planning is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly.…
-
Splitting an overlong document into two Started this topic · Documentation › Wiki requests · 22 Jan 2026 · 28 likes Posting this under the heading it deserves: Splitting an overlong document into two Everything below is what sits behind that. Trying to work out what would count as…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #23 · Practice › Storage & stability · 22 Jan 2026 · 30 likes I want to gently push back on the reply above about storage extrapolation. The advice is sound and the confidence is not. We are extrapolating from stability data on a…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #53 · Practice › Storage & stability · 19 Jan 2026 · 14 likes Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the contents degrade. Smaller fill volumes lose less to…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #16 · Practice › Administration · 18 Jan 2026 · 0 likes On post #14 — agreed on the reasoning, with one qualification. The single most common technique error described here is drawing to the wrong graduation because the…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #37 · Research Methods › N-of-1 designs · 17 Jan 2026 · 10 likes A photograph or a device reading is a harder record than a recollection, and where one is available it should be the record. The answer changed when I changed how I was…
-
Filter needles: when they help and what they cost you Replied, post #15 · Devices › Syringes & needles · 31 Dec 2025 · 0 likes Post #13 and I disagree about the size of the effect, not about the direction. U-100 means the barrel is graduated for a solution containing one hundred units of…
-
Tracking that stops updating and then resumes — the long version Replied, post #55 · Sourcing › Logistics · 23 Dec 2025 · 1 like Post #52 is the version of this I will quote in future. One addition. Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by…
-
Pooling trials with different estimands — what changed since Replied, post #63 · Evidence › Meta-analyses · 9 Dec 2025 · 0 likes Post #59 and I disagree about the size of the effect, not about the direction. Fixed-effect and random-effects models answer different questions. The first assumes one…
-
Oral versus injectable exposure: comparing apples to a different fruit Replied, post #22 · Compounds › Oral incretins · 29 Nov 2025 · 3 likes Picking up post #19: that is the part I would want checked first. Tablet integrity matters more than people expect for a formulation that depends on an absorption…
-
IGF-1 as a surrogate endpoint and its limitations Replied, post #4 · Compounds › Secretagogues & GH axis · 27 Nov 2025 · 0 likes What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate sample size, IGF-1 as primary outcome, muscle and strength…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #75 · Practice › Dosing & titration · 14 Nov 2025 · 0 likes Post #74 is right about the mechanism and I think understates the practical bit. Steady state means the plasma concentration is stable from dose to dose. That happens…
-
Cross-border purchase rules within the EU Replied, post #38 · Regional › European Union · 13 Nov 2025 · 27 likes This follows post #37 rather than contradicting it. Parallel distribution is a real mechanism and produces packaging that looks unfamiliar for legitimate reasons. It…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #32 · Sourcing › Vendor reports · 6 Nov 2025 · 15 likes Post #28 put the caveat in the right place and I want to underline it. Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a…
-
An inter-laboratory comparison on one lot, tabulated — what changed since Replied, post #12 · Analytics › Method validation · 3 Nov 2025 · 0 likes Reading back through the inter-laboratory comparison threads from last year, the same three questions come up every time and only one of them has ever been answered…
-
Availability by country, dated, with primary sources Replied, post #35 · Access › International · 27 Oct 2025 · 8 likes Everything in post #33 holds. The case it does not cover is the one I have. Summaries lag badly in this area. Where a decision matters, read the current official…
-
A 40-week log with the measurement method stated Replied, post #44 · Outcomes › Progress reports · 21 Oct 2025 · 5 likes Weighing daily and reporting weekly is a better protocol than weighing weekly, because it separates the measurement frequency from the reporting frequency. Worth one…
-
Sleep tracking data and its considerable limitations Replied, post #41 · Wellbeing › Sleep · 20 Oct 2025 · 0 likes Consistency of timing does more for most people's sleep than any intervention discussed in this subcategory.
-
New subcategory: rationale and scope Replied, post #57 · Meta › Announcements · 18 Oct 2025 · 4 likes No disagreement from me. Posting only so the question does not look ignored.
-
Payment mechanics and the recovery options that do not exist Replied, post #12 · Sourcing › Payments · 18 Oct 2025 · 29 likes On post #8 — agreed on the reasoning, with one qualification. Payment mechanics is one of those subjects where the general answer and the answer for a specific case…
-
Request: a diff view for wiki revisions — the long version Replied, post #57 · Meta › Feature requests · 18 Oct 2025 · 17 likes Small request: let me filter Latest by whether I have read the topic. Unread exists as a tab and does not combine with anything else, so a busy category is either all…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #107 · Practice › Administration · 12 Oct 2025 · 3 likes Adding a reference point for pinch. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted appropriately.
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #42 · Compounds › Tirzepatide · 11 Oct 2025 · 3 likes Everything in post #40 holds. The case it does not cover is the one I have. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent…
-
About the North America category Replied, post #4 · Regional › North America · 6 Oct 2025 · 0 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #20 · Compounds › Semaglutide · 3 Oct 2025 · 9 likes Post #18 describes the usual case. This is about the unusual one. The 165 to 184 hour half-life range gets quoted as a fixed number. It is a range across a studied…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #71 · Evidence › Preprints · 1 Oct 2025 · 0 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
What a 2 ppm match establishes, and what it does not Replied, post #54 · Analytics › Mass spectrometry · 26 Sep 2025 · 26 likes The honest summary of what a mass result buys you: it narrows the field of what the material could be, considerably. It never closes it, and no certificate should be…
-
Temperature loggers worth the money — the long version Replied, post #44 · Devices › Cold chain · 22 Sep 2025 · 10 likes Assessing an excursion: if a package sat at room temperature for a time, visual inspection (cloudiness, discoloration, particles) can alert you to problems. Not visible…
-
How to read a forest plot, properly, from scratch Replied, post #30 · Evidence › Trials · 20 Sep 2025 · 0 likes Post #27 is the version of this I will quote in future. One addition. Discontinuation handling is the methodological detail that most changes a result and gets the…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #82 · Evidence › Study critique · 15 Sep 2025 · 5 likes Post #79 is the version of this I will quote in future. One addition. Per-protocol and intention-to-treat analyses answer different questions and neither is the honest…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #61 · Evidence › Study critique · 14 Sep 2025 · 30 likes Post #57 and I disagree about the size of the effect, not about the direction. Marking my uncertainty on Reverse causation explicitly. I am confident about the…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #108 · Compounds › Retatrutide · 9 Sep 2025 · 2 likes Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that question gets answered. Using phase 2 results to make…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #8 · Data & Tools › Datasets · 6 Sep 2025 · 0 likes The arithmetic in post #7 is right; the assumption feeding it is the part to check. The claim about Aggregated purity results across four upthread is stronger than its…
-
About the European Union category Replied, post #5 · Regional › European Union · 6 Sep 2025 · 7 likes Members outside the union should note that essentially none of this transfers, including the parts phrased generally. I am confident about the direction and much less…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #49 · Sourcing › Vendor reports · 1 Sep 2025 · 10 likes Post #47 answers the question as asked. The question underneath it is different. Do not adjust a reported figure. Post what the laboratory said and put your…
-
Hypertension improvement and when medication needs revisiting Replied, post #20 · Clinical › Comorbidities · 22 Aug 2025 · 16 likes A note on how hypertension improvement gets discussed rather than on hypertension improvement itself: the confident posts get the replies and the careful ones get…
-
Hepatic impairment and the absence of data Replied, post #14 · Clinical › Special populations · 17 Aug 2025 · 2 likes The absence of a reported signal in a population that was barely enrolled is not evidence about that population.
-
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #19 · Evidence › Preprints · 16 Aug 2025 · 9 likes Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed is useful but comes at the cost of not yet having…
-
A comparison of home results against a laboratory result on the same vial Replied, post #25 · Analytics › Home & field testing · 15 Aug 2025 · 26 likes Where a home observation and an independent result disagree, the independent one is measuring something more specific. That does not make the home observation useless —…
-
Managing an unplanned gap in supply — what changed since Replied, post #36 · Access › Shortages · 12 Aug 2025 · 0 likes I have been on both sides of the Managing an unplanned gap argument in this category within eighteen months, which should tell you how strong the evidence for either…
-
Specification in the result column: why that is a meaningful error Replied, post #29 · Analytics › COA interpretation · 10 Aug 2025 · 0 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #27 · Evidence › Journal club · 8 Aug 2025 · 2 likes Post #26 is right about the mechanism and I think understates the practical bit. A request rather than an answer: could whoever has the primary source for indirect…
-
A ten-fold dose error caught before injection — one year on Replied, post #131 · Devices › Syringes & needles · 4 Aug 2025 · 13 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
-
How to research a compound with no human data without deceiving yourself Replied, post #103 · Compounds › Other compounds · 4 Aug 2025 · 31 likes Post #99 describes the usual case. This is about the unusual one. Reading this research a compound thread as someone who came in with a fixed view: the third and…
-
When a preprint is the best available evidence and we say so Started this topic · Evidence › Preprints · 25 Jul 2025 · 0 likes When a preprint is the best available evidence and we say so — that is the question, and I have not found it answered plainly anywhere I have looked. A preprint…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #55 · Evidence › Trials · 12 Jul 2025 · 31 likes I would be cautious about generalising from the Sample size calculations example above. It is a good example. It is one example.
-
Washout: how long is long enough, and for what purpose Replied, post #44 · Pharmacology › Pharmacokinetics · 11 Jul 2025 · 26 likes That is a fair summary of where the discussion has got to.
-
Reading a chromatogram someone posted without axes Replied, post #56 · Analytics › HPLC & UHPLC · 9 Jul 2025 · 30 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #3 · Compounds › Cagrilintide & amylin analogues · 4 Jul 2025 · 21 likes Narrowing the opening post, because the general version has more than one answer. Native amylin has awkward physical properties — it aggregates readily, which is why a…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #151 · Practice › Reconstitution · 1 Jul 2025 · 25 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #55 · Compounds › Repair & healing peptides · 1 Jul 2025 · 12 likes Picking up post #54: that is the part I would want checked first. TB-500 and thymosin beta-4 was covered in the wiki last year and the page has a review date on it,…
-
A report I filed that turned out to be wrong, and the correction Replied, post #128 · Sourcing › Vendor reports · 29 Jun 2025 · 29 likes I had written a reply contradicting post #124 and deleted it. Here is what survived. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if…
-
Sequence verification for an obscure compound: how it is done Replied, post #76 · Compounds › Other compounds · 28 Jun 2025 · 0 likes Helpful, and easy to find again, which is half of what a good reply is.
-
Journal club: SURMOUNT-1, read without the press release Replied, post #146 · Evidence › Journal club · 27 Jun 2025 · 6 likes Checked the SURMOUNT-1 claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #28 · Nutrition & Training › Protein & intake · 6 Jun 2025 · 0 likes This follows post #25 rather than contradicting it. Taking Tracking intake seriously for a moment rather than deflecting: the honest position is that the community has…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #15 · Sourcing › Regulatory · 31 May 2025 · 0 likes Post #11 and I disagree about the size of the effect, not about the direction. On compound being unapproved, I would rather understate and be corrected upward than…
-
Individual participant data versus aggregate data Replied, post #32 · Evidence › Meta-analyses · 21 May 2025 · 8 likes Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by quality, to see whether the pooled estimate changes. Robust results…
-
Reading a trial's population section before its results — does this still hold? Replied, post #126 · Evidence › Trials · 20 May 2025 · 1 like Post #124 put the caveat in the right place and I want to underline it. A trial that answers a slightly different question from the one you have is the normal situation…
-
Which panel is worth repeating and which is worth ignoring Replied, post #16 · Clinical › Bloodwork · 10 May 2025 · 0 likes Coming back to post #14, because the follow-up matters more than the original answer. Two sentences on panel and then I will stop, because the rest is speculation and…
-
Adjudicated events and why the definition matters — the long version Replied, post #144 · Evidence › Trials · 9 May 2025 · 27 likes Worth separating two things that post #142 runs together. The confident answers on Adjudicated events and the well-sourced answers are not the same answers, which is…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Started this topic · Data & Tools › Calculators · 7 May 2025 · 29 likes The question in the title: Why the titration planner refuses to produce a schedule below a floor I will give what I have already checked below so nobody repeats it. A…
-
Telehealth prescribing models in the US Replied, post #92 · Regional › North America · 1 May 2025 · 17 likes Telehealth prescribing: widespread in the US and varying in quality. Models without a clinician reviewing measurements and history are not recommended by this…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #25 · Compounds › Oral incretins · 30 Apr 2025 · 23 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
-
Criticising the method without criticising the authors Replied, post #60 · Evidence › Study critique · 29 Apr 2025 · 1 like Where the criticising the method without criticising discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies".…
-
Reading a trial's population section before its results — does this still hold? Replied, post #44 · Evidence › Trials · 27 Apr 2025 · 9 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #23 · Sourcing › Independent verification · 20 Apr 2025 · 5 likes Verification records are dated because they expire in usefulness. A result from two years ago describes a lot from two years ago.
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #20 · Sourcing › Independent verification · 15 Apr 2025 · 27 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #10 · Evidence › Trials · 12 Apr 2025 · 2 likes On Comparators chosen for regulatory reasons I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #11 · Evidence › Trials · 10 Apr 2025 · 21 likes Taking Sample size calculations seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison,…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #52 · Clinical › Comorbidities · 7 Apr 2025 · 26 likes This follows post #51 rather than contradicting it. The question underneath obstructive sleep apnoea is usually "how would I tell?" rather than "what is true?", and…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #54 · Analytics › Mass spectrometry · 2 Apr 2025 · 10 likes Reading back through the adducts threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That seems…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #34 · Practice › Interactions · 2 Apr 2025 · 0 likes Adding the measurement that post #33 says would settle it. Food interactions: most interactions are absorption interactions. Some medications absorb better with food,…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #85 · Documentation › Doc review · 1 Apr 2025 · 32 likes On post #84 — agreed on the reasoning, with one qualification. The most useful review comment names a sentence and says what is wrong with it. General approval and…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #9 · Compounds › Cagrilintide & amylin analogues · 22 Mar 2025 · 3 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #111 · Pharmacology › Receptor biology · 16 Mar 2025 · 26 likes GIP receptor biology is genuinely contested. Both agonism and antagonism have been argued to produce weight reduction, and the fact that the field can hold both…
-
Certificates issued by the seller versus by a laboratory Replied, post #2 · Analytics › COA interpretation · 9 Mar 2025 · 0 likes Certificates from a supplier's own laboratory are not independent by definition. That is not an accusation, it is a description, and it is why independent submission…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #52 · Evidence › Journal club · 6 Mar 2025 · 0 likes On post #50 — agreed on the reasoning, with one qualification. What would change my mind on SUSTAIN 6 is a second dataset collected by someone with no stake in the…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #124 · Sourcing › Regulatory · 5 Mar 2025 · 0 likes Import rules for personal quantities differ from commercial import rules and both differ by country. Establishing your own position is not something a forum can do for…
-
Consistent declarations and why they matter more than clever ones Replied, post #121 · Sourcing › Logistics · 3 Mar 2025 · 21 likes Adding what did not work for me on consistent declarations, since the failures never get written up and they are half the useful information.
-
Adjudicated events and why the definition matters — the long version Replied, post #32 · Evidence › Trials · 3 Mar 2025 · 0 likes Worth separating two things that post #30 runs together. Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it…
-
Follow-up: Requesting a page: what makes a good request Replied, post #2 · Documentation › Wiki requests · 14 Feb 2025 · 0 likes Authority and authorship: if you think a maintained page needs input from someone with specific expertise (a clinician, an analytical chemist) suggest who might…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #86 · Compounds › Other compounds · 10 Feb 2025 · 0 likes Colour in a lyophilised cake is worth noting for the less common compounds specifically, because some of them are genuinely not white and a member expecting white will…
-
Protein density versus volume when you cannot eat much Replied, post #79 · Nutrition & Training › Protein & intake · 6 Feb 2025 · 0 likes Where intake has fallen a long way, protein is usually the first thing to fall because it is the least appealing macronutrient when appetite is reduced.
-
Retatrutide's phase 2 heart-rate signal and how to think about it — the long version Replied, post #2 · Compounds › Retatrutide · 2 Feb 2025 · 1 like The opening post is the version of this I will quote in future. One addition. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this…